Dark Forest Capital Management’s Travere Therapeutics TVTX Stock Holding History

Dark Forest Capital Management’s Portfolio TVTX Stock Details TVTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-28,483	Closed	-$681K	–	1359
2025 Q3	$681K	Sell	28,483 -24,775	-47%	-$466K	0.03%	848
2025 Q2	$788K	Buy	53,258 +42,467	+394%	+$704K	0.03%	811
2025 Q1	$193K	Buy	+10,791	New	+$219K	0.01%	1148
2023 Q4	–	Sell	-28,083	Closed	-$251K	–	1062
2023 Q3	$251K	Buy	+28,083	New	+$396K	0.02%	959
2022 Q1	–	Sell	-120	Closed	-$4K	–	1769
2021 Q4	$4K	Sell	120 -322	-73%	-$9.07K	﹤0.01%	1238
2021 Q3	$11K	Buy	442 +83	+23%	+$1.52K	﹤0.01%	975
2021 Q2	$5K	Buy	+359	New	+$7.08K	﹤0.01%	697

Other funds holding TVTX

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dark Forest Capital Management's TVTX Position: Q4 2025 in Review

Dark Forest Capital Management sold out of Travere Therapeutics (TVTX) in Q4 2025, closing a stake of 28,483 shares — an estimated $681K sold.

Dark Forest Capital Management first reported a position in TVTX in Q2 2021 and held it in 7 quarters. The position peaked at $788K in Q2 2025. 278 funds tracked by Wall St. Rank hold TVTX as of Q4 2025.

Dark Forest Capital Management reported no remaining Travere Therapeutics position as of Q4 2025 after selling out during the quarter.
Dark Forest Capital Management sold 28,483 Travere Therapeutics shares in Q4 2025, an estimated $681K.
Dark Forest Capital Management first reported a position in Travere Therapeutics in Q2 2021 and held it in 7 quarters.
Dark Forest Capital Management's Travere Therapeutics position peaked at $788K in Q2 2025.
278 funds tracked by Wall St. Rank held Travere Therapeutics as of Q4 2025.

Based on Dark Forest Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.